Search research articles
Contact Us
Filters
Showing results (61-70 of 112) with videos related to
Page
of 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2016
A Quantitative Analysis of Subclonal and Clonal Gene Mutations before and after Therapy in Chronic Lymphocytic Leukemia
Nisar A Amin, Erlene Seymour, Kamlai Saiya-Cork, et al.
Genes, Chromosomes & Cancer
|
September 7, 2012
Incidence and clinical implications of ATM aberrations in chronic lymphocytic leukemia
Peter Ouillette, Jinghui Li, Rita Shaknovich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 6, 2011
The prognostic significance of various 13q14 deletions in chronic lymphocytic leukemia
Peter Ouillette, Roxane Collins, Sajid Shakhan, et al.
The Journal of Clinical Investigation
|
August 22, 2017
Ultrasensitive mutation detection identifies rare residual cells causing acute myelogenous leukemia relapse
Brian Parkin, Angelina Londoño-Joshi, Qing Kang, et al.
Scientific Reports
|
July 1, 2020
Hybrid Modelling of Transarterial Chemoembolisation Therapies (TACE) for Hepatocellular Carcinoma (HCC)
H Perfahl, H V Jain, T Joshi, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
November 30, 2007
Three-dimensional sonographic assessment of fetal urine production before and after laser surgery in twin-to-twin transfusion syndrome
M Yamamoto, M Essaoui, B Nasr, et al.
JCI Insight
|
January 27, 2026
AML PATIENTS WITH WILDTYPE TP53 BUT DEFECTIVE TP53-MEDIATED APOPTOSIS HAVE A DISMAL SURVIVAL
Josephine Dubois, Anthony Palmer, Darren King, et al.
Blood
|
April 26, 2008
Genomic complexity identifies patients with aggressive chronic lymphocytic leukemia
Lisa Kujawski, Peter Ouillette, Harry Erba, et al.
Blood
|
April 21, 2010
Multiple distinct molecular mechanisms influence sensitivity and resistance to MDM2 inhibitors in adult acute myelogenous leukemia
Jianting Long, Brian Parkin, Peter Ouillette, et al.
Acta Neurologica Scandinavica
|
August 22, 2013
Baseline [(123) I]FP-CIT SPECT (DaTSCAN) severity correlates with medication use at 3 years in Parkinson's disease
T Nissen, N Malek, K A Grosset, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 112) with videos related to
Sort By:
Page
of 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2016
A Quantitative Analysis of Subclonal and Clonal Gene Mutations before and after Therapy in Chronic Lymphocytic Leukemia
Nisar A Amin, Erlene Seymour, Kamlai Saiya-Cork, et al.
Genes, Chromosomes & Cancer
|
September 7, 2012
Incidence and clinical implications of ATM aberrations in chronic lymphocytic leukemia
Peter Ouillette, Jinghui Li, Rita Shaknovich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 6, 2011
The prognostic significance of various 13q14 deletions in chronic lymphocytic leukemia
Peter Ouillette, Roxane Collins, Sajid Shakhan, et al.
The Journal of Clinical Investigation
|
August 22, 2017
Ultrasensitive mutation detection identifies rare residual cells causing acute myelogenous leukemia relapse
Brian Parkin, Angelina Londoño-Joshi, Qing Kang, et al.
Scientific Reports
|
July 1, 2020
Hybrid Modelling of Transarterial Chemoembolisation Therapies (TACE) for Hepatocellular Carcinoma (HCC)
H Perfahl, H V Jain, T Joshi, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
November 30, 2007
Three-dimensional sonographic assessment of fetal urine production before and after laser surgery in twin-to-twin transfusion syndrome
M Yamamoto, M Essaoui, B Nasr, et al.
JCI Insight
|
January 27, 2026
AML PATIENTS WITH WILDTYPE TP53 BUT DEFECTIVE TP53-MEDIATED APOPTOSIS HAVE A DISMAL SURVIVAL
Josephine Dubois, Anthony Palmer, Darren King, et al.
Blood
|
April 26, 2008
Genomic complexity identifies patients with aggressive chronic lymphocytic leukemia
Lisa Kujawski, Peter Ouillette, Harry Erba, et al.
Blood
|
April 21, 2010
Multiple distinct molecular mechanisms influence sensitivity and resistance to MDM2 inhibitors in adult acute myelogenous leukemia
Jianting Long, Brian Parkin, Peter Ouillette, et al.
Acta Neurologica Scandinavica
|
August 22, 2013
Baseline [(123) I]FP-CIT SPECT (DaTSCAN) severity correlates with medication use at 3 years in Parkinson's disease
T Nissen, N Malek, K A Grosset, et al.
Page
of 12